SEC Filing Summary: Amedica Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on August 24, 2016. The report covers events occurring on the same date. Note: While the request metadata references "Sintx Technologies, Inc.", the filing text explicitly identifies the registrant as Amedica Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a regulatory event rather than financial performance.
Material Changes
On August 24, 2016, the U.S. Food and Drug Administration (FDA) granted clearance for expanded sizes of the Valeo® II Lateral Lumbar interbody fusion device. This expands the product line available for lateral lumbar interbody fusion procedures.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items beyond the announcement of the FDA clearance.
Investor Verification Checklist
- Verify the specific device sizes included in the FDA clearance for the Valeo® II system.
- Confirm the commercial availability timeline for the newly cleared device sizes.
- Review subsequent filings for any financial impact or sales data related to the expanded product line.